RESUMEN
Measurement of basal adrenocorticotrophic hormone (ACTH) is currently used to diagnose pituitary pars intermedia dysfunction (PPID) in horses, yet a systematic review of the evidence for its use has not been undertaken. This study aimed to systematically review evidence regarding the sensitivity and specificity of the basal ACTH diagnostic test. Electronic databases were systematically searched in January 2019, September 2020 and January 2021, for English language publications published prior to these dates. Screening, data extraction and quality assessment of publications was undertaken by the authors using predefined criteria. Study design, methodology and information reported in included studies were assessed using Standards for Reporting of Diagnostic Accuracy (STARD) checklists. Risk of bias and applicability were appraised using the Quality Assessment tool for Diagnostic Accuracy Studies (QUADAS-2) quality assessment tool. Due to identified biases and marked between-study variations, meta-analysis was not undertaken. After removal of duplicates, 415 publications were identified, of which 25 were evaluated in full, with 11 of these meeting inclusion criteria. In most studies, basal ACTH was reported to have good sensitivity (overall median 75.5%; interquartile range [IQR], 64.0-86.5%; range, 36.0-100%) and excellent specificity (overall median, 95.2%; IQR, 84.2-98.9%; range, 63.3-100%). However, QUADAS-2 and STARD assessment highlighted that studies did not utilise optimal study design and/or study populations for the evaluation of a diagnostic test and the majority were subject to bias, or provided insufficient information to fully assess possible biases. Based on this review, basal ACTH performed better at ruling out PPID than detecting it.
Asunto(s)
Hormona Adrenocorticotrópica/sangre , Enfermedades de los Caballos/diagnóstico , Enfermedades de la Hipófisis/veterinaria , Animales , Enfermedades de los Caballos/sangre , Caballos , Enfermedades de la Hipófisis/diagnóstico , Adenohipófisis Porción Intermedia/metabolismo , Sensibilidad y EspecificidadRESUMEN
Pergolide, a dopamine agonist, is commonly administered to manage pituitary pars intermedia dysfunction (PPID), a progressive neurodegenerative disease prevalent in aged horses. However, available evidence regarding pergolide's efficacy in improving clinical and endocrine parameters is limited. The aim of this systematic review was to assess published literature and evaluate evidence regarding whether pergolide treatment results in improvement of clinical signs and/or adrenocorticotrophic hormone (ACTH) concentration compared to no treatment or other unlicensed treatments. Systematic searches of electronic databases were undertaken in April 2019, repeated in August and October 2019, and updated in July 2020. English language publications published prior to these dates were included. Screening, data extraction and quality assessment of publications was undertaken individually by the authors using predefined criteria and subsequently cross-checked. Modified critically appraised topic data collection forms were used to extract data. Due to marked between-study variations, meta-analysis was not undertaken. After removal of duplicate records; 612 publications were identified, of which 129 abstracts were screened for eligibility and 28 publications met criteria for inclusion in the review. Most studies were descriptive case series, cohort studies or non-randomised, uncontrolled field trials. Despite marked variation in study populations, case selection, diagnostic protocols, pergolide dose, follow-up period and outcome measures, in the vast majority of the included studies, pergolide was reported to provide overall clinical improvement in >75% of cases. However, reported improvements in individual clinical signs varied widely. A reduction in plasma ACTH concentrations was reported in 44-74% of cases, while normalisation to within reported reference intervals occurred in 28-74% of cases.
Asunto(s)
Enfermedades de los Caballos/tratamiento farmacológico , Pergolida/uso terapéutico , Enfermedades de la Hipófisis/veterinaria , Adenohipófisis Porción Intermedia/efectos de los fármacos , Hormona Adrenocorticotrópica/sangre , Animales , Caballos , Pergolida/administración & dosificación , Enfermedades de la Hipófisis/tratamiento farmacológico , Resultado del TratamientoRESUMEN
Currently, the dental profession has no comprehensive classification method or scheme to identify the many types of propagating cracks in human tooth structure. This article presents two new and practical classification systems that encompass numerous types of cracks. The first is the more simplified--the Surface and Position Classification System. The second and more comprehensive system is the Directional Crack Propagation System.
Asunto(s)
Síndrome de Diente Fisurado/clasificación , Síndrome de Diente Fisurado/patología , Análisis del Estrés Dental , HumanosRESUMEN
Prompt restoration of function and esthetic appearance of dentition can avoid psychological stress and functional problems. Surgical procedures that require long-term bone deposition and soft-tissue healing can accompany periodontal and orthodontic reinforcement, but other less invasive, immediate, intermediate, and final treatment plans can be initiated with good results.